Publications by authors named "Michael Philbin"

Claim this Profile
R
Real-world outcomes and practice patterns among patients with schizophrenia when switched from oral antipsychotics to long-acting injectable formulations after hospitalization.
John M Kane, Jose M Rubio, Julian Casciano, Zenobia Dotiwala, Rolf T Hansen Iii, Michael J Philbin

Psychiatry Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current policies on early detection of prostate cancer create overdiagnosis and inequity with minimal benefit.
Andrew Vickers, Frank O'Brien, Francesco Montorsi, David Galvin, Ola Bratt, Michael Philbin

BMJ· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of antipsychotic treatment switching in patients with schizophrenia, bipolar, and major depressive disorders.
Rajeev Ayyagari, Darren Thomason, Fan Mu, Michael Philbin, Benjamin Carroll

J Med Econ· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deutetrabenazine for tardive dyskinesia and chorea associated with Huntington's disease: a review of clinical trial data.
Daniel O Claassen, Michael Philbin, Benjamin Carroll

Expert Opin Pharmacother· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing Dungeness River Functionality and Effectiveness of Best Management Practices (BMPs) Using an Ecological Functional Approach.
Eric S Hall, Robert K Hall, Sherman Swanson, Wilson Yee, Don Kozlowski, Michael J Philbin

Am J Environ Engineer· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, safety, and quality-of-life of treatments for acute relapses of multiple sclerosis: results from a literature review of randomized controlled trials.
Jessica Costello, Annete Njue, Matthew Lyall, Anne Heyes, Nancy Mahler, Michael Philbin

Degener Neurol Neuromuscul Dis· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Ecological Function Approach to Managing Harmful Cyanobacteria in Three Oregon Lakes: Beyond Water Quality Advisories and Total Maximum Daily Loads (TMDLs).
Eric S Hall, Robert K Hall, Joan L Aron, Sherman Swanson, Michael J Philbin

Water (Basel)· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Retrospective Medical Record Review of Utilization Patterns and Medical Resource Use Associated with Repository Corticotropin Injection among Patients with Rheumatologic Diseases in the United States.
Winnie W Nelson, Michael J Philbin, Jack R Gallagher, Kylee Heap, Susan Carroll

Rheumatol Ther· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Demographics, treatment patterns, and healthcare utilization and cost of repository corticotropin injection in patients with systemic lupus erythematosus or rheumatoid arthritis.
Bingcao Wu, Gaurav Deshpande, Tao Gu, Breanna Popelar, Michael Philbin

J Med Econ· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic burden of sarcoidosis in a commercially-insured population in the United States.
J Bradford Rice, Alan White, Andrea Lopez, Alexandra Conway, Aneesha Wagh, Michael Philbin

J Med Econ· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Economic Evaluation of Repository Corticotropin Injection: A Narrative Literature Review of Treatment Efficacy and Healthcare Resource Utilization for Seven Key Indications.
Michael Philbin, John Niewoehner, George J Wan

Adv Ther· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medical resource utilization in dermatomyositis/polymyositis patients treated with repository corticotropin injection, intravenous immunoglobulin, and/or rituximab.
Tyler Knight, T Christopher Bond, Breanna Popelar, Li Wang, John W Niewoehner, Michael Philbin

Clinicoecon Outcomes Res· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare Costs and Resource Utilization in Patients with Infantile Spasms Treated with H.P. Acthar Gel(®).
Laura S Gold, Patricia B Schepman, Wei-Jhih Wang, Michael Philbin, John Niewoehner

Adv Ther· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare resource utilization and work loss in dermatomyositis and polymyositis patients in a privately-insured US population.
J Bradford Rice, Alan White, Andrea Lopez, Philip Galebach, Patricia Schepman, Michael Philbin

J Med Econ· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An ecological function and services approach to total maximum daily load (TMDL) prioritization.
Robert K Hall, David Guiliano, Sherman Swanson, Michael J Philbin, John Lin

Environ Monit Assess· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis